Stay updated on Tralokinumab Combo in Japanese AD: Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.

Latest updates to the Tralokinumab Combo in Japanese AD: Clinical Trial page
- Check2 days agoChange DetectedAdded a government funding/status notice and a page revision tag (Revision: v3.4.1). Removed publications that were automatically filled from PubMed.SummaryDifference0.6%

- Check9 days agoChange DetectedAdditions include showing the glossary toggle and a new Revision: v3.4.0, while deletions remove older items such as Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4; capitalization tweaks are also present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed on the page, indicating a UI version update rather than a change to study data or content.SummaryDifference0.0%

- Check45 days agoChange DetectedLocations section updated to include multiple Japanese locations under a consolidated Locations area. The page shows a new Revision: v3.3.3.SummaryDifference1%

- Check73 days agoChange DetectedPublications section text was updated to indicate that publications are automatically filled from PubMed and may not be about the study, and a 'Revision: v3.3.2' tag was added. The previous explanatory wording about PubMed publications was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedThe government funding status notice has been removed from the page. This change does not affect the study details or results.SummaryDifference0.3%

Stay in the know with updates to Tralokinumab Combo in Japanese AD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.